Efficacy of Trans Abdominis Plane Block for Post Cesarean... | NCT06556381

Studies
Efficacy of Trans Abdominis Plane Block for Post Cesarean Delivery Analgesia

NCT06556381

Sponsor

Qassim University

Status

Completed

Last Update Posted

May 27, 2026Actual

Enrollment

100Actual

Phase

Not Applicable

Conditions

Analgesia

Interventions

TAP block

Countries

Saudi Arabia

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Aug 2024

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Apr 1, 2024Actual

Primary Completion Date

Oct 30, 2025Actual

Completion Date

Apr 30, 2026Actual

First Submitted Date

Aug 1, 2024

First Submission Date that Met QC Criteria

Aug 13, 2024

First Posted Date

Aug 16, 2024Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

May 21, 2026

Last Update Posted Date

May 27, 2026Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Yes

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

FDAAA801 Violation

Not provided

Description Module

Brief Summary

Relief from pain is part of the fundamental human right to health. (1) However, available evidence indicates an increasingly detailed understanding of the pathophysiology of pain and general inadequacy of its treatment.

Detailed Description

Background: Relief from pain is part of the fundamental human right to health. (1) However, available evidence indicates an increasingly detailed understanding of the pathophysiology of pain and general inadequacy of its treatment.

Rationale: Assessment and Improving the Pain Management Modality

Study objectives: In this study, determined the efficacy of TAP block in patients undergoing cesarean section.

Methods:

This study is a cross-sectional study. It is a multi-centric study as it was conducted in different Governmental hospitals.

Design Module

Study Type

Interventional

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not Applicable

Interventional Study Design

Allocation

Biospecimen

No data available

No data is available for this block.

Enrollment

100Actual

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Group A,	Experimental	women who received TAP block.	Procedure: TAP block
Group B	Active Comparator	Received Usual modality of analgesics (Paracetamol, Tramadol, and Pethidine).	Procedure: TAP block

Interventions

Name	Type	Description	Arm Group Labels	Other Names
TAP block	Procedure	Women will receive TAP block.	Group A, Group B

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Pain Score	NRS	24 hours

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Age: 20-50 years
Patients of >50 kg or <100 kg weight.
Urgency: Elective, Emergent and Urgent cases

Exclusion Criteria:

Patients of <50 kg or >100 kg weight
Any contraindication to any of anesthesia medications
Patient unable to understand numeric rating scale (NRS)

Accepts Healthy Volunteers

Sex

Female

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

50 Years

Standard Ages

Adult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Mohammed Abaalkhayl, MD	Qassim University	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Qassim University Medical City		Buraidah	Al-Qassim Region	51411	Saudi Arabia

IPD Sharing Statement Module

Plan to Share IPD

Undecided

Description

Not provided

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided

Condition Browse Module

MeSH Terms

ID	Term
D000377	Agnosia
D010146	Pain

Ancestor Terms

ID	Term
D010468	Perceptual Disorders
D019954	Neurobehavioral Manifestations
D009461	Neurologic Manifestations
D009422	Nervous System Diseases

Browse Leaves

Not provided

Browse Branches

Not provided